2016年《实用肝脏病杂志》精彩回顾

doi:10.3969/j.issn.1672-5069.2017.01.001

Abstract

Chen Yuanwen, Fan Jiangao.. Highlights of Journal of Practical Hepatology in 2016[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 1-3.

[1] 陈新月,柳雅立. 慢性乙型肝炎患者如何获得临床治愈. 实用肝脏病杂志,2016,19（3）:257-260.
[2] 中华医学会肝病学分会.伴有肾脏损伤及其高危风险的慢性乙型肝炎患者抗病毒治疗专家共识. 实用肝脏病杂志,2016,19（4）:ⅰ-ⅵ.
[3] 邓浩辉,许敏,高洪波,关玉娟. 广州地区424例乙型肝炎患者病毒基因亚型分布与乙型肝炎疾病谱的关系探讨. 实用肝脏病杂志,2016,19（5）: 528-531.
[4] 杜晓菲,马丽娜,柳雅立,等. 39例成人急性乙型肝炎患者血清HBV基因变异检测及其临床意义探讨.实用肝脏病杂志,2016,19（5）:524-527.
[5] 陆伟,张占卿,沈芳,等. 血清HBsAg和HBV DNA定量水平预测慢性乙型肝炎患者肝组织炎症活动度和纤维化程度的评价.实用肝脏病杂志,2016,19（1）:20-24.
[6] 郭素娟,李娟,李智伟. 132例家族聚集性慢性乙型肝炎病毒感染者影响自然病程进展的相关因素分析.实用肝脏病杂志,2016,19（1）:41-44.
[7] 杨蕊旭,胡春秀,陈国凤,等. 慢性乙型肝炎患者血清脂质组学研究. 实用肝脏病杂志,2016,19（6）:657-662.
[8] 张舰琼,徐亮,李萍,等. 四种方法诊断慢性乙型肝炎合并轻度肝脂肪变患者肝纤维化比较. 实用肝脏病杂志,2016,19（6）:663-668.
[9] 邱波,朱玲,陈艳,等. 妊娠期不同阶段给予替比夫定阻断乙型肝炎病毒宫内母婴传播的研究. 实用肝脏病杂志,2016,19（4）:428-431.
[10] 卢婷,宋玉霞,李成忠. 核苷（酸）类药物治疗慢性乙型肝炎和乙型肝炎肝硬化患者血清磷变化及其相关影响因素分析.实用肝脏病杂志,2016,19（2）:168-171.
[11] 李晨,游绍莉,吕飒,等. 恩替卡韦导致乙型肝炎肝硬化患者周围神经病变临床特征. 实用肝脏病杂志,2016,19（2）:200-203.
[12] 朱芳,颜学兵,王家猛,等. 抗丙型肝炎病毒治疗过程中甲状腺功能异常与病毒学应答关系研究. 实用肝脏病杂志,2016,19（5）:540-543.
[13] 张龙玉,闫亮,郝书理,等. 乙醛脱氢酶2基因多态性与酒精性肝病患者饮酒特点和疾病发生的关系.实用肝脏病杂志,2016,19（3）:292-296.
[14] 张龙玉,孙颖,黄昂,等. 酒精性肝病患者肝组织NLRP3炎症复合体基因水平检测及其意义. 实用肝脏病杂志,2016,19（6）:678-682.
[15] 杨硕,吕栋,王天懿,等. FibroTouch 脂肪衰减参数对非酒精性脂肪性肝病患者肝脏脂肪变程度的诊断价值. 实用肝脏病杂志,2016,19（1）:50-54.
[16] 范晓棠,闫亚宁,石绣江,等. 慢性乙型肝炎与非酒精性脂肪性肝病患者内皮功能检测. 实用肝脏病杂志,2016,19（5）:536-539.
[17] 朱婵艳,瞿冀琛,曹海霞,等. 非酒精性脂肪性肝病与原发性支气管肺腺癌发生的相关性研究. 实用肝脏病杂志,2016,19（6）:683-686.
[18] 胡海东, 张见增. 216例肝硬化门静脉高压症患者CT血管成像门静脉侧支血管表现研究. 实用肝脏病杂志,2016,19（1）:73-76.
[19] 叶玉玲,权明珠,叶萍,等. 乙型肝炎肝硬化患者心电图和超声心动图检查异常及其临床意义.实用肝脏病杂志,2016,19（5）:574-577.
[20] 魏新朋,韩际奥,高晓,等. 肝硬化患者病情与小肠细菌过度生长变化关系探讨. 实用肝脏病杂志,2016,19（3）:310-313.
[21] 孙华银,杨丽坤,王沛陵,等. 酒精性肝硬化患者住院费用及影响因素分析. 实用肝脏病杂志,2016,19（1）:68-72.
[22] 周静,苏菲. 失代偿期肝硬化患者肝损伤急性加重100例临床分析. 实用肝脏病杂志,2016,19（3）:314-317.
[23] 季淑静,王梦洁, 陈金军. 慢加急性乙型肝炎肝衰竭患者贫血特点分析. 实用肝脏病杂志,2016,19（1）:55-59.
[24] 刘菲菲,吴吉圆,张海月,等. 慢加急性乙型肝炎肝衰竭临床特征及血浆置换治疗对其预后的影响.实用肝脏病杂志,2016,19（2）:188-191.
[25] 程亚,乔晓斐,荚卫东. 特利加压素治疗失代偿期乙型肝炎肝硬化患者消退腹水的作用及对肝肾功能的影响.实用肝脏病杂志,2016,19（6）:687-691.
[26] 吴武军,于咏田,杜立学,等. 脾腔小口径分流联合断流术对肝硬化门静脉高压症患者肝血流动力学和储备功能的影响.实用肝脏病杂志,2016,19（2）:196-199.
[27] 张宏春,耿喆. 增强CT扫描与超声造影对肝脏占位性病变的临床诊断价值比较.实用肝脏病杂志,2016,19（6）:696-699.
[28] 肖潇,杨均,颜綦先,等. TACE治疗53例Child C级肝硬化并发小肝癌患者疗效评价.实用肝脏病杂志,2016,19（2）:204-207.

Highlights of Journal of Practical Hepatology in 2016

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Ren Yufei, Chen Xiaoqing, Kong Weizong, et al.. Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro [J]. Journal of Practical Hepatology, 2019, 22(6): 804-807.
[3]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[4]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[5]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[6]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[7]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[8]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[9]	Pan Meimin, Li Wenjuan, Jiang Fangqing, et al.. Changes of serum IL-17A,fibroblast growth factor and IL-7 levels in patients with hepatitis C virus infection [J]. Journal of Practical Hepatology, 2019, 22(6): 840-843.
[10]	Li Yingyi, Guo Cuifen, Zhang Ruinan, et al.. Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 848-851.
[11]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[12]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[13]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[14]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[15]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.